1204669-72-6

Basic information

• Product Name: 4-(3-bromo-4-fluorophenyl)-3-(4-((3-hydroxypropyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazole-5(4H)-one
• Synonyms: 4-(3-bromo-4-fluorophenyl)-3-(4-((3-hydroxypropyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazole-5(4H)-one
• CAS NO: 1204669-72-6
• Molecular Weight: 400.164
• Mol File: 1204669-72-6.mol

Chemical Properties

• CAS DataBase Reference: 4-(3-bromo-4-fluorophenyl)-3-(4-((3-hydroxypropyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazole-5(4H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-bromo-4-fluorophenyl)-3-(4-((3-hydroxypropyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazole-5(4H)-one(1204669-72-6)
• EPA Substance Registry System: 4-(3-bromo-4-fluorophenyl)-3-(4-((3-hydroxypropyl)amino)-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazole-5(4H)-one(1204669-72-6)

Safety Data

• Hazardous Substances Data: 1204669-72-6(Hazardous Substances Data)

Upstream product

• 1204669-71-5 4-(3-bromo-4-fluorophenyl)-3-{4-[(3-methoxypropyl)amino]-1,2,5-oxadiazol-3-yl}-1,2,4-oxadiazol-5(4H)-one 
• 914471-43-5 3‐(4‐amino‐1,2,5‐oxadiazol‐3‐yl)‐4‐(3‐bromo‐4‐fluorophenyl)‐1,2,4‐oxadiazol‐5‐one 
• 2019140-71-5 4‐(3‐bromo‐4‐fluorophenyl)‐3‐(4‐nitro‐1,2,5‐oxadiazol‐3‐yl)‐4,5‐dihydro‐1,2,4‐oxadiazol‐5‐one 
• 156-87-6 propan-1-ol-3-amine 
• 1204669-95-3 N-hydroxy-4-[(3-methoxypropyl)amino]-1,2,5-oxadiazole-3-carboximidoyl chloride 
• 1204669-94-2 N'-hydroxy-4-[(3-methoxypropyl)amino]-1,2,5-oxadiazole-3-carboximidamide 
• 914471-60-6 N-{4-[4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl}-2,2,2-trifluoroacetamide 

Downstream Products

• 1204669-73-7 3-{4-[(3-azidopropyl)amino]-1,2,5-oxadiazol-3-yl}-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one 
• 1204669-39-5 4-({3-[(aminosulfonyl)amino]propyl}amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide 
• 1204669-76-0 N-[3-({4-[4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl}amino)propyl]sulfamide 
• 1204669-75-9 3-{4-[(3-aminopropyl)amino]-1,2,5-oxadiazol-3-yl}-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydroiodide 

Relevant articles and documents

Oxadiazole derivative, preparation method and applications thereof

The invention relates to an oxadiazole derivative, a preparation method and applications thereof, wherein the oxadiazole derivative has a structure represented by a formula (I), and R1, X and R2 are defined in the specification.

INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR, ITS PREPARATION METHOD AND THE USE THEREOF

The present invention relates to Indoleamine 2,3-dioxygenase inhibitor represented by formula (I), its preparation method and the use thereof. The inhibitor of Indoleamine 2,3-dioxygenase (IDO for short) is the derivative of (Z)-N'-hydroxy-N-phenylformami

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER

In some embodiments, the methods involve the use of a combination of at least two of the following: an inhibitor of indoleamine-2,3-dioxygenase (IDO), an inhibitor of the PD-L1/PD-1 pathway, an inhibitor of CTLA-4, an inhibitor of CD25, or IL-7. The inven

1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE

The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.